image
Cyclerion Therapeutics, Inc. CYCN
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 2.58
45.8 %
$ 6.99 M
Market Cap
-0.6
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2023-12-31 0.00% 52.00% 78.26%
Annual Report FY 10-K 2022-12-31 -91.05% 15.25% 19.61%
Annual Report FY 10-K 2021-12-31 44.60% 28.91% 32.08%
Annual Report FY 10-K 2020-12-31 -49.06% 39.93% 35.01%
Annual Report FY 10-K 2019-12-31 0.00% -4.97% -8.49%
Annual Report FY 10-K 2018-12-31 0.00% -22.71% -22.71%
Annual Report FY 10-K 2017-12-31 0.00% -47.78% -47.78%
Annual Report FY 10-K 2016-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2024-09-30 0.00% 0.00% 81.25%
Quarterly Report Q2 8-K 2024-06-30 0.00% 68.38% 67.38%
Quarterly Report Q1 8-K 2024-03-31 0.00% 77.25% 77.02%
Quarterly Report Q4 8-K 2023-12-31 0.00% 75.91% 75.57%
Quarterly Report Q3 8-K 2023-09-30 0.00% 173.64% 43.29%
Quarterly Report Q2 8-K 2023-06-30 0.00% 68.67% 68.41%
Quarterly Report Q1 8-K 2023-03-31 0.00% 47.75% 45.76%
Quarterly Report Q4 8-K 2022-12-31 792.86% 34.73% 48.75%
Quarterly Report Q3 8-K 2022-09-30 0.00% 9.00% 6.01%
Quarterly Report Q2 8-K 2022-06-30 -97.60% 17.54% 16.96%
Quarterly Report Q1 8-K 2022-03-31 262.90% 3.19% 3.07%
Quarterly Report Q4 8-K 2021-12-31 36.84% 43.96% 25.42%
Quarterly Report Q3 8-K 2021-09-30 -80.75% 39.99% 48.19%
Quarterly Report Q2 8-K 2021-06-30 300.53% 17.16% 17.77%
Quarterly Report Q1 8-K 2021-03-31 -93.89% 33.76% 34.94%
Quarterly Report Q4 8-K 2020-12-31 -91.02% 26.20% 27.69%
Quarterly Report Q3 8-K 2020-09-30 -71.39% 31.13% 22.26%
Quarterly Report Q2 8-K 2020-06-30 -53.99% 39.44% 40.49%
Quarterly Report Q1 8-K 2020-03-31 0.00% 45.89% 44.92%
Quarterly Report Q4 8-K 2019-12-31 0.00% 15.69% 13.97%
Quarterly Report Q3 8-K 2019-09-30 0.00% 6.72% 4.34%
Quarterly Report Q2 8-K 2019-06-30 0.00% -8.30% -10.99%
Quarterly Report Q1 8-K 2019-03-31 0.00% -47.85% -47.85%
Quarterly Report Q4 8-K 2018-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2018-09-30 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2018-06-30 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2018-03-31 0.00% 0.00% 0.00%